• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

集成集成系统生物学特征选择和双模态深度神经网络用于乳腺癌预后预测。

Integrating ensemble systems biology feature selection and bimodal deep neural network for breast cancer prognosis prediction.

机构信息

Department of Electrical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan.

Department of Electrical Engineering and Graduate Institute of Communication Engineering, National Taiwan University, Taipei, 10617, Taiwan.

出版信息

Sci Rep. 2021 Jul 21;11(1):14914. doi: 10.1038/s41598-021-92864-y.

DOI:10.1038/s41598-021-92864-y
PMID:34290286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8295302/
Abstract

Breast cancer is a heterogeneous disease. To guide proper treatment decisions for each patient, robust prognostic biomarkers, which allow reliable prognosis prediction, are necessary. Gene feature selection based on microarray data is an approach to discover potential biomarkers systematically. However, standard pure-statistical feature selection approaches often fail to incorporate prior biological knowledge and select genes that lack biological insights. Besides, due to the high dimensionality and low sample size properties of microarray data, selecting robust gene features is an intrinsically challenging problem. We hence combined systems biology feature selection with ensemble learning in this study, aiming to select genes with biological insights and robust prognostic predictive power. Moreover, to capture breast cancer's complex molecular processes, we adopted a multi-gene approach to predict the prognosis status using deep learning classifiers. We found that all ensemble approaches could improve feature selection robustness, wherein the hybrid ensemble approach led to the most robust result. Among all prognosis prediction models, the bimodal deep neural network (DNN) achieved the highest test performance, further verified by survival analysis. In summary, this study demonstrated the potential of combining ensemble learning and bimodal DNN in guiding precision medicine.

摘要

乳腺癌是一种异质性疾病。为了指导每个患者的适当治疗决策,需要有可靠的预后生物标志物,以便能够进行可靠的预后预测。基于微阵列数据的基因特征选择是一种系统地发现潜在生物标志物的方法。然而,标准的纯统计特征选择方法往往无法结合先验的生物学知识,选择缺乏生物学见解的基因。此外,由于微阵列数据的高维性和低样本量特性,选择稳健的基因特征是一个内在具有挑战性的问题。因此,我们在这项研究中结合了系统生物学特征选择和集成学习,旨在选择具有生物学见解和稳健预后预测能力的基因。此外,为了捕捉乳腺癌的复杂分子过程,我们采用了多基因方法,使用深度学习分类器来预测预后状态。我们发现所有的集成方法都可以提高特征选择的稳健性,其中混合集成方法的效果最好。在所有的预后预测模型中,双模态深度神经网络(DNN)在测试性能上达到了最高,这一点通过生存分析得到了进一步验证。总之,这项研究证明了在指导精准医学方面结合集成学习和双模态 DNN 的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/2db851f05d8c/41598_2021_92864_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/b688010ca842/41598_2021_92864_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/6b1c1022d884/41598_2021_92864_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/72db00449f8d/41598_2021_92864_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/79b12e390551/41598_2021_92864_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/06de7f1168e7/41598_2021_92864_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/2db851f05d8c/41598_2021_92864_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/b688010ca842/41598_2021_92864_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/6b1c1022d884/41598_2021_92864_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/72db00449f8d/41598_2021_92864_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/79b12e390551/41598_2021_92864_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/06de7f1168e7/41598_2021_92864_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae4/8295302/2db851f05d8c/41598_2021_92864_Fig6_HTML.jpg

相似文献

1
Integrating ensemble systems biology feature selection and bimodal deep neural network for breast cancer prognosis prediction.集成集成系统生物学特征选择和双模态深度神经网络用于乳腺癌预后预测。
Sci Rep. 2021 Jul 21;11(1):14914. doi: 10.1038/s41598-021-92864-y.
2
Enhancing the prediction of IDC breast cancer staging from gene expression profiles using hybrid feature selection methods and deep learning architecture.使用混合特征选择方法和深度学习架构增强从基因表达谱预测浸润性导管癌乳腺癌分期的能力。
Med Biol Eng Comput. 2023 Nov;61(11):2895-2919. doi: 10.1007/s11517-023-02892-1. Epub 2023 Aug 2.
3
Stable feature selection utilizing Graph Convolutional Neural Network and Layer-wise Relevance Propagation for biomarker discovery in breast cancer.利用图卷积神经网络和逐层相关性传播进行稳定特征选择,以发现乳腺癌的生物标志物。
Artif Intell Med. 2024 May;151:102840. doi: 10.1016/j.artmed.2024.102840. Epub 2024 Mar 11.
4
Identifying cancer biomarkers by network-constrained support vector machines.通过网络约束支持向量机识别癌症生物标志物。
BMC Syst Biol. 2011 Oct 12;5:161. doi: 10.1186/1752-0509-5-161.
5
NNBGWO-BRCA marker: Neural Network and binary grey wolf optimization based Breast cancer biomarker discovery framework using multi-omics dataset.基于神经网络和二进制灰狼优化的乳腺癌生物标志物发现框架,利用多组学数据集。
Comput Methods Programs Biomed. 2024 Sep;254:108291. doi: 10.1016/j.cmpb.2024.108291. Epub 2024 Jun 18.
6
Robust edge-based biomarker discovery improves prediction of breast cancer metastasis.基于稳健边缘的生物标志物发现可提高乳腺癌转移的预测能力。
BMC Bioinformatics. 2020 Sep 30;21(Suppl 14):359. doi: 10.1186/s12859-020-03692-2.
7
Machine Learning and Deep Learning Approaches in Breast Cancer Survival Prediction Using Clinical Data.使用临床数据进行乳腺癌生存预测的机器学习和深度学习方法
Folia Biol (Praha). 2019;65(5-6):212-220. doi: 10.14712/fb2019065050212.
8
Multi-Modal Classification for Human Breast Cancer Prognosis Prediction: Proposal of Deep-Learning Based Stacked Ensemble Model.基于深度学习的堆叠集成模型在人类乳腺癌预后预测中的多模态分类。
IEEE/ACM Trans Comput Biol Bioinform. 2022 Mar-Apr;19(2):1032-1041. doi: 10.1109/TCBB.2020.3018467. Epub 2022 Apr 1.
9
Predicting drug-target interaction network using deep learning model.利用深度学习模型预测药物-靶标相互作用网络。
Comput Biol Chem. 2019 Jun;80:90-101. doi: 10.1016/j.compbiolchem.2019.03.016. Epub 2019 Mar 25.
10
Network-based drug sensitivity prediction.基于网络的药物敏感性预测。
BMC Med Genomics. 2020 Dec 28;13(Suppl 11):193. doi: 10.1186/s12920-020-00829-3.

引用本文的文献

1
Exploiting common patterns in diverse cancer types via multi-task learning.通过多任务学习探索不同癌症类型中的常见模式。
NPJ Precis Oncol. 2024 Oct 29;8(1):245. doi: 10.1038/s41698-024-00700-z.
2
Optimizing hybrid ensemble feature selection strategies for transcriptomic biomarker discovery in complex diseases.优化混合集成特征选择策略以发现复杂疾病中的转录组生物标志物。
NAR Genom Bioinform. 2024 Jul 11;6(3):lqae079. doi: 10.1093/nargab/lqae079. eCollection 2024 Sep.
3
A machine learning and deep learning-based integrated multi-omics technique for leukemia prediction.

本文引用的文献

1
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).生物标志物在乳腺癌中的临床应用:欧洲肿瘤标志物小组(EGTM)的更新指南。
Eur J Cancer. 2017 Apr;75:284-298. doi: 10.1016/j.ejca.2017.01.017. Epub 2017 Feb 28.
2
The importance of regulatory ubiquitination in cancer and metastasis.调节性泛素化在癌症和转移中的重要性。
Cell Cycle. 2017 Apr 3;16(7):634-648. doi: 10.1080/15384101.2017.1288326. Epub 2017 Feb 6.
3
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible.
一种基于机器学习和深度学习的用于白血病预测的集成多组学技术。
Heliyon. 2024 Feb 1;10(3):e25369. doi: 10.1016/j.heliyon.2024.e25369. eCollection 2024 Feb 15.
4
Breast cancer survival prognosis using the graph convolutional network with Choquet fuzzy integral.基于 Choquet 模糊积分的图卷积网络的乳腺癌生存预后预测。
Sci Rep. 2023 Sep 7;13(1):14757. doi: 10.1038/s41598-023-40341-z.
5
Development and validation of a prediction model for the diagnosis of breast cancer based on clinical and ultrasonic features.基于临床和超声特征的乳腺癌诊断预测模型的开发与验证
Gland Surg. 2023 Jun 30;12(6):736-748. doi: 10.21037/gs-22-663. Epub 2023 Jun 5.
6
OEDL: an optimized ensemble deep learning method for the prediction of acute ischemic stroke prognoses using union features.OEDL:一种使用联合特征预测急性缺血性中风预后的优化集成深度学习方法。
Front Neurol. 2023 Jun 21;14:1158555. doi: 10.3389/fneur.2023.1158555. eCollection 2023.
7
Deep learning facilitates multi-data type analysis and predictive biomarker discovery in cancer precision medicine.深度学习有助于癌症精准医学中的多数据类型分析和预测性生物标志物发现。
Comput Struct Biotechnol J. 2023 Jan 31;21:1372-1382. doi: 10.1016/j.csbj.2023.01.043. eCollection 2023.
8
Learning from small medical data-robust semi-supervised cancer prognosis classifier with Bayesian variational autoencoder.从少量医学数据中学习——基于贝叶斯变分自编码器的稳健半监督癌症预后分类器
Bioinform Adv. 2023 Jan 9;3(1):vbac100. doi: 10.1093/bioadv/vbac100. eCollection 2023.
9
Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.通过系统生物学方法和全基因组微阵列数据鉴定口腔鳞状细胞癌的药物靶点,用于深度学习和药物设计规范的药物发现。
Int J Mol Sci. 2022 Sep 8;23(18):10409. doi: 10.3390/ijms231810409.
2017年的STRING数据库:质量可控的蛋白质-蛋白质相互作用网络,广泛可用。
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368. doi: 10.1093/nar/gkw937. Epub 2016 Oct 18.
4
Cross-Talk between AURKA and Plk1 in Mitotic Entry and Spindle Assembly.有丝分裂启动和纺锤体组装过程中AURKA与Plk1之间的相互作用
Front Oncol. 2015 Dec 23;5:283. doi: 10.3389/fonc.2015.00283. eCollection 2015.
5
FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.FBXW7抑制胆管癌细胞的上皮-间质转化、干性和转移潜能。
Oncotarget. 2015 Mar 20;6(8):6310-25. doi: 10.18632/oncotarget.3355.
6
Using protein interaction database and support vector machines to improve gene signatures for prediction of breast cancer recurrence.利用蛋白质相互作用数据库和支持向量机改进用于预测乳腺癌复发的基因特征。
J Med Signals Sens. 2013 Apr;3(2):87-93.
7
Role of epidermal growth factor receptor in breast cancer.表皮生长因子受体在乳腺癌中的作用。
Breast Cancer Res Treat. 2012 Nov;136(2):331-45. doi: 10.1007/s10549-012-2289-9. Epub 2012 Oct 17.
8
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.2000 个乳腺肿瘤的基因组和转录组结构揭示了新的亚群。
Nature. 2012 Apr 18;486(7403):346-52. doi: 10.1038/nature10983.
9
Heterogeneity in breast cancer.乳腺癌的异质性。
J Clin Invest. 2011 Oct;121(10):3786-8. doi: 10.1172/JCI60534. Epub 2011 Oct 3.
10
Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.雌激素受体(ESR1)mRNA 表达与他莫昔芬在治疗和预防雌激素受体阳性乳腺癌中的获益。
J Clin Oncol. 2011 Nov 1;29(31):4160-7. doi: 10.1200/JCO.2010.32.9615. Epub 2011 Sep 26.